Drucker, who is an endocrinologist, Banting and Best Diabetes Centre-Novo Nordisk Chair in Incretin Biology and professor of medicine in the division of endocrinology at University of Toronto and has a laboratory based in the Lunenfeld Tanenbaum Research Institute at Mount Sinai Hospital in Toronto, said GLP-1s have gone from scientists questioning why anyone would want to use an injectable sulfonylurea to a class of drugs that have numerous benefits, including: reductions in albuminuria, atherosclerosis, body weight, blood pressure, cell death, fibrosis, glucose, gut motility, inflammation, oxidative stress, platelet aggregation, postprandial lipemia and thrombosis
independent drug stores
Reddy's, who said in a press release: "As the first company to receive market authorisation for generic semaglutide injection in Canada, we remain dedicated to expanding access to innovative, high-quality, affordable GLP-1 [glucagon-like peptide-1] treatments for patients with diabetes in the country"
Oxidative stress, dysfunctional glucose metabolism and Alzheimer disease
E.SzocsK.SorescuG